作者
Aleksey V. Zaitsev,Dmitry V. Amakhin,Alexandra V. Dyomina,М. В. Захарова,Julia L. Ergina,Tatyana Y. Postnikova,Georgy P. Diespirov,L. G. Magazanik
摘要
Epilepsy is one of the prevalent cerebral diseases, and despite
intensive research of this pathology for many years, modern medicine
cannot effectively control seizure manifestations in almost a third
of patients. In epilepsy, there is a reorganization of neural networks,
which is the result of the death of some neurons and the formation
of new neuronal connections with altered properties. In this review,
we focused on the analysis of changes in the properties of a key
element of neural networks, the chemical synapse, immediately after
epileptic activity, during epileptogenesis, and in chronic epilepsy.
Since the synapse includes not only neuronal pre- and postsynaptic
parts, but also glial components, our consideration includes changes
in the properties of astrocytes and microglia. Epileptic activity
causes numerous modifications in synapse function: changes in the
probability of mediator release, the alteration of subunit composition
of postsynaptic receptors, impairments of synaptic plasticity, and
changes in morphology and activity of astrocytes and microglia.
Glial cells release several gliatransmitters and cytokines, which
in turn modify synaptic transmission. In some cases, the combination
of these changes is favorable and allows compensating almost completely the
consequences of epileptic activity for the nervous system. However,
quite often, these changes, on the contrary, trigger a cascade of
events leading to epilepsy and long-term disturbances in the functioning
of neural networks. Over the past 10 years, significant progress
has been achieved in deciphering these changes and their mechanisms,
which is covered in our review. However, until now, researchers
have not yet reached consensus on which particular modifications
in the functioning of synapses provide optimal compensation and
are able to prevent epileptogenesis. This knowledge could be the
basis for the development of effective methods for epileptogenesis prevention
and epilepsy treatment.